oral glp-1 agonists The development of an receptor agonist for the management o | DDDT glp 1 agonist oral or
Description
Giorgino F, Penfornis A, Pechtner V, Gentilella R, Corcos A
What is Tirzepatide, and how is it a 'silver bullet' against obesity
2017;26(4):620-632.e626
A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study) J
These criteria and collected variables were established to isolate the impact of GLP-1 prescriptions on study outcomes while controlling for potential confounding factors, with a specific focus on the risk of depression, anxiety, and suicide
doi: 10.1093/ndt/gfab045
